Journal rankings · indicator year 2021
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2021
Immunology journal rankings 2021
87 ranked journals · Subfield in Immunology and Microbiology
Immunology has 87 ranked journals in 2021. The median journal has an OJR of 0.93, below the world average of 1.00, unchanged on 2020; Q1 starts at OJR 1.50. The top three are Immunity, Science Immunology, and Nature Immunology.
Ranks and citation indicators: 2021. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2018–2020, the window the 2021 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
87 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2020. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2018–2020, the window the 2021 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2018–2020 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2012 to 2021. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 6.08Q1 | 30.82 8.52 up from 2020 | 753 | 99% | $10,400 | ||
2Science ImmunologyAmerican Association for the Advancement of Science · United States | 4.55Q1 | 25.05 11.86 up from 2020 | 347 | 62% | — | ||
3Nature ImmunologyNature Portfolio · United States | 4.23Q1 | 19.90 4.73 up from 2020 | 682 | 62% | $12,690 | ||
4Nature reviews. ImmunologyNature Portfolio · United Kingdom | 3.75Q1 | 38.69 19.40 up from 2020 | 502 | 57% | — | ||
5Journal of AutoimmunityElsevier BV · United Kingdom | 3.67Q1 | 18.13 10.71 up from 2020 | 383 | 70% | $5,420 | ||
6Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 3.65Q1 | 11.04 1.50 up from 2020 | 150 | 49% | $5,490 | ||
7The Journal of Experimental MedicineRockefeller University Press · United States | 3.41Q1 | 15.04 2.61 up from 2020 | 766 | 99% | — | ||
8Seminars in ImmunopathologySpringer Science+Business Media · Germany | 3.09Q1 | 11.98 2.38 up from 2020 | 152 | 67% | $3,790 | ||
9Seminars in ImmunologyElsevier BV · United States | 2.76Q1 | 10.61 0.77 down from 2020 | 144 | 55% | $4,370 | ||
10Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.66Q1 | 11.82 4.36 up from 2020 | 1,493 | 61% | $4,900 | ||
11Cellular and Molecular ImmunologySpringer Nature · China | 2.61Q1 | 14.70 8.45 up from 2020 | 526 | 100% | $5,190 | ||
12Annual Review of ImmunologyAnnual Reviews · United States | 2.57Q1 | 34.72 2.91 up from 2020 | 79 | 53% | — | ||
13Immunity & AgeingOABioMed Central · United Kingdom | 2.38Q1 | 11.16 3.76 up from 2020 | 101 | 100% | $3,190 | ||
14Frontiers in ImmunologyOAFrontiers Media · Switzerland | 2.20Q1 | 9.88 1.13 up from 2020 | 9,398 | 100% | $3,801 | ||
15Mucosal ImmunologyOAElsevier BV · United States | 2.17Q1 | 8.92 1.77 up from 2020 | 349 | 100% | $4,370 | ||
16ImmunologyWiley · United Kingdom | 1.92Q1 | 6.97 0.65 down from 2020 | 368 | 83% | $5,330 | ||
17Clinical ImmunologyElsevier BV · Netherlands | 1.80Q1 | 10.18 6.75 up from 2020 | 545 | 46% | $4,400 | ||
18Journal of Innate ImmunityOAKarger Publishers · Switzerland | 1.74Q1 | 6.28 0.34 down from 2020 | 142 | 100% | $3,590 | ||
19Inflammation ResearchSpringer Science+Business Media · Switzerland | 1.69Q1 | 7.61 2.84 up from 2020 | 286 | 34% | $4,790 | ||
20Immune NetworkOASouth Korea | 1.69Q1 | 6.24 0.27 down from 2020 | 143 | 100% | — | ||
21BioDrugsAdis, Springer Healthcare · Switzerland | 1.58Q1 | 8.36 1.73 up from 2020 | 182 | 63% | $5,190 | ||
22Clinical & Translational ImmunologyOAWiley · Australia | 1.50Q1 | 6.92 0.40 up from 2020 | 202 | 100% | $3,070 | ||
23Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.44Q2 | 5.53 1.00 up from 2020 | 426 | 88% | $3,816 | ||
24Journal of Leukocyte BiologyOxford University Press · United States | 1.38Q2 | 5.78 0.96 up from 2020 | 758 | 44% | $3,800 | ||
25Trends in ImmunologyElsevier BV · United Kingdom | 1.35Q2 | 13.61 1.15 up from 2020 | 337 | 58% | $7,030 | ||
26International ImmunologyOxford University Press · United Kingdom | 1.33Q2 | 4.56 0.35 up from 2020 | 252 | 50% | $3,530 | ||
27Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.32Q2 | 5.39 0.86 up from 2020 | 434 | 33% | — | ||
28The Journal of ImmunologyAmerican Association of Immunologists · United States | 1.26Q2 | 5.14 0.07 up from 2020 | 2,026 | 21% | $3,500 | ||
29Cytokine & Growth Factor ReviewsElsevier BV · United Kingdom | 1.22Q2 | 18.02 10.05 up from 2020 | 174 | 61% | $4,900 | ||
30Genes and ImmunitySpringer Nature · United States | 1.18Q2 | 6.21 3.07 up from 2020 | 107 | 73% | $3,190 | ||
31The AAPS JournalSpringer Science+Business Media · United States | 1.17Q2 | 3.98no change | 333 | 60% | $5,090 | ||
32Cellular ImmunologyElsevier BV · Netherlands | 1.14Q2 | 3.79 1.02 down from 2020 | 382 | 36% | $3,550 | ||
33BMC ImmunologyOABioMed Central · United Kingdom | 1.08Q2 | 3.85 0.18 down from 2020 | 151 | 100% | $3,090 | ||
34Current Protocols in ImmunologyWiley · United States | 1.08Q2 | 3.33 0.49 down from 2020 | 70 | — | $5,050 | ||
35Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.06Q2 | 5.47 1.85 up from 2020 | 417 | 64% | $4,990 | ||
36Molecular ImmunologyElsevier BV · Netherlands | 1.05Q2 | 4.06 0.19 down from 2020 | 804 | 20% | $3,340 | ||
37Immunology LettersElsevier BV · Netherlands | 1.05Q2 | 3.97 0.38 up from 2020 | 375 | 27% | $3,290 | ||
38Immunologic ResearchSpringer Science+Business Media · United States | 1.05Q2 | 5.20 1.92 up from 2020 | 174 | 48% | $2,890 | ||
39CytokineElsevier BV · United Kingdom | 1.03Q2 | 3.91 0.09 up from 2020 | 993 | 36% | $3,220 | ||
40Immunology and Cell BiologyWiley · Australia | 1.02Q2 | 4.26 0.39 down from 2020 | 304 | 59% | $3,750 | ||
41Fish & Shellfish ImmunologyElsevier BV · United Kingdom | 1.01Q2 | 4.54 0.10 up from 2020 | 2,335 | 14% | $4,330 | ||
42International Reviews of ImmunologyTaylor & Francis · United States | 1.01Q2 | 5.25 1.23 up from 2020 | 78 | 30% | — | ||
43Drugs in R&DOAAdis, Springer Healthcare · New Zealand | 0.93Q2 | 3.66 0.94 up from 2020 | 101 | 100% | $3,490 | ||
44American Journal of Reproductive ImmunologyWiley · United Kingdom | 0.93Q2 | 3.65 0.22 up from 2020 | 421 | 9% | $4,460 | ||
45European Journal of ImmunologyWiley · Germany | 0.92Q3 | 4.63 1.03 up from 2020 | 682 | 78% | $4,550 | ||
46Journal of ImmunotoxicologyOAInforma · United States | 0.91Q3 | 3.53 0.65 up from 2020 | 53 | 100% | $2,306 | ||
47Immunological ReviewsWiley · United States | 0.90Q3 | 11.38 1.70 up from 2020 | 265 | 63% | $5,000 | ||
48ImmunometabolismOAUnited Kingdom | 0.87Q3 | 3.22 0.78 down from 2020 | 50 | 100% | — | ||
49ImmunobiologyOAElsevier BV · Germany | 0.82Q3 | 3.18 0.42 up from 2020 | 304 | 22% | $2,840 | ||
50ImmunoHorizonsOAUnited States | 0.82Q3 | 2.90 0.68 down from 2020 | 160 | 100% | $1,700 |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2021. Corpus-wide, 87.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
35 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2018–2020, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2021. Publication window: 2018–2020. How these summaries are calculated
- Ranked journals
- 87
- Window papers (baseline)
- 77,362 +7.3% from indicator year 2018
- Median OJR
- 0.932 +1.2% from indicator year 2018
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2018–2020 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.